PEA for dogs and cats: From reducing pain to improving allergies
Palmitoylethanolamide, or PEA, is a clinically proven ingredient for dogs and cats that can help with a range of health concerns.
Let’s take a look at the scientific literature.
Clinical Results in Companion Animals
Skin and Allergic Conditions
Most veterinary research to date has focused on dermatology. Laboratory studies on feline and canine skin mast cells (immune cells) have shown that PEA can reduce allergic hypersensitivity.
In canine skin, PEA reduced the amount of histamine released and even decreased the dilation of small blood vessels, which may result in less redness and irritation.
Results from individual studies:
- Dogs with dermatitis: Palmitoylethanolamide (15 mg/kg daily for 7 days) delayed the onset of itching and skin lesions compared with placebo.
- Dogs following an allergic challenge: A single dose of PEA at 10 mg/kg reduced the size of allergic skin reactions.
- In a randomized, double-blind study, dogs with atopic dermatitis showed a statistically significant reduction in skin symptoms after 45 days of PEA supplementation (15 mg/kg daily).
- In a study involving 160 dogs, 56 days of PEA supplementation (10 mg/kg daily) reduced itching and skin lesions, while 45% of the dogs regained a quality of life comparable to that of healthy animals.
- In 67% of cats with skin lesions, one month of PEA supplementation (10 mg/kg daily) improved itching and redness, with no reported adverse effects.
- In cats following steroid withdrawal, PEA (15 mg/kg) prolonged the time without an allergic flare-up (an average of 40 days vs. 22 days with placebo).
Benefits for Chronic Pain and Gastrointestinal Health
PEA has also been studied in animals with chronic pain and gastrointestinal conditions.
Pain and mobility:
In a clinical study, dogs with osteoarthritis received PEA + quercetin for 4 weeks (24 mg/kg/day), resulting in:
- reduced chronic pain,
- improved mobility,
- reduced lameness.
Gastrointestinal health:
In dogs with chronic diarrhea, PEA (10 mg/kg daily for 30 days) reduced the inflammatory bowel disease activity index, supporting its anti-inflammatory effects in the gastrointestinal tract.
PEA – an endogenous compound for dogs and cats with a broad range of effects
Research suggests that palmitoylethanolamide may provide benefits across several areas:
| Skin & immune system |
| Nervous system & mobility |
| Gastrointestinal health |
Palmitoylethanolamide is therefore a remarkable compound with the potential to significantly improve vitality and quality of life.
Sources: